REV3Lp, the catalytic subunit of DNA polymerase zeta, is the major participant in translesion DNA synthesis. Recent evidence suggests that REV3L has an important role in the maintenance of genome stability despite its mutagenic characteristics. Such a function makes it a cancer susceptibility candidate gene. To investigate association between REV3L polymorphisms and lung cancer risk in a Chinese population, we first genotyped 15 common polymorphisms of the REV3L gene and found that three single nucleotide polymorphisms (rs465646, rs459809 and rs1002481) were significantly associated with lung cancer risk. One of the strongest associations observed was for the 3 0 -terminal untranslated region (3 0 UTR) 460 T4C polymorphism (rs465646) (adjusted odds ratio (OR) ¼ 0.69 for TC/CC; P ¼ 0.007, compared with TT). Similar results were obtained in a subsequent replication study (adjusted OR ¼ 0.72; P ¼ 0.016). Combined data from the two studies of 1072 lung cancer patients and 1064 cancer-free controls generated an even stronger association (adjusted OR ¼ 0.71; P ¼ 3.04 Â 10 À4 ). This 3 0 UTR 460 T4C variant was predicted to modulate the binding of several micro RNAs. Surface plasmon resonance analysis and luciferase assays showed that the T allele demonstrated a stronger binding affinity for miR-25 and miR-32, resulting in significantly weaker reporter expression levels. Additional experiments revealed that miR-25/32 could downregulate endogenous REV3L. Furthermore, the tumor-suppressing role of REV3L was confirmed by the foci formation assay. These results support our hypothesis that the REV3L rs465646 variant modifies lung cancer susceptibility in Chinese Han population by affecting miRNA-mediated gene regulation.
INTRODUCTION
Lung cancer remains the leading cause of cancer-related deaths worldwide. 1 Exposure to environmental carcinogens, especially tobacco smoke, has been proved to be the most important risk factor for lung cancer. However, only a fraction of smokers develop lung cancer, suggesting interplay between genetic susceptibility and environmental exposure.
Cells constantly encounter various carcinogens or cytotoxic agents that directly or indirectly induce DNA damage, leading to DNA cross-links, DNA strand breaks or mutations that cause genomic instability. DNA repair mechanisms, including nucleotide excision repair, base excision repair, mismatch repair and doublestrand break repair are responsible for the integrity of the genome. 2 Besides, eukaryotic cells from yeast to humans possess DNA post-replication repair or DNA damage tolerance system. Translesion DNA synthesis (TLS) and homologous DNA recombination are two major post-replicational repair pathways. 3 The ubiquitous TLS consists of a series of specialized polymerases, including polymerase k, z, Z and i. 4 In DNA replication, replication complex will be blocked at DNA lesions, where cells will initiate the TLS system to avoid disastrous collapses of the replication forks and double-strand DNA breaks. 5 In TLS, the proliferating cell nuclear antigen recruits some low-fidelity DNA polymerases to replace the replicative polymerase to incorporate nucleotides opposite to damaged nucleotide residues rather than directly repairing them, 6 which is followed by resumption of processive DNA synthesis. 7 Nevertheless, these special polymerases are regarded as error-prone, because the fidelity of these special polymerases has been estimated to be B1000 --4000-fold lower than the replicative DNA polymerases. 6 --8 The TLS processes sacrifice the fidelity of the chromosome to ensure the accomplishment of DNA replication. 9 Polymerase Zeta (Pol z or Pol Zeta) consists of two subunits, catalytic REV3 and structural REV7. This enzyme confers most of spontaneous and induced mutagenesis found in yeast. 10 The yeast REV3 mutant strain exhibits reduced levels of mutagenesis when treated with mutagens. 11 The function of vertebrate REV3p shares some similarity with its yeast counterpart, despite that a region of B1400 amino acids does not exist in yeast. REV3-null mouse embryonic fibroblasts are more sensitive to UV irradiation, mitomycin C and g irradiation with increased chromosomal abnormalities.
12 DT40 cells deficient in REV3 showed dramatic sensitivity to cisplatin, mitomycin C and transplatin. 3, 13 These results indicate that mammalian REV3L participates in cell tolerance, which is consistent with its homolog in yeast.
However, unlike the non-essential role in yeast, mammalian REV3 has a critical role in maintenance of genome stability. Human REV3L is ubiquitously expressed in normal and malignant human tissues, suggesting its necessity. Disruption of mREV3 in mice lead to embryonic lethality; 14, 15 moreover, REV3L À/À showed dramatic genome instability represented by chromosome rearrangements and translocations. 3, 12 The expression of human REV3L can be upregulated at the transcriptional level in response to N-methyl-N'-nitro-Nnitrosoguanidine. Although N-methyl-N'-nitro-Nnitrosoguanidine-induced mutation was REV3 dependent, suppression of REV3L by small interfering RNA had no effect on spontaneous mutation. 16 Recent findings indicate that REV3L can attenuate accumulation of spontaneous double strand break (DSB) and prevent tumorigenesis. 17 Thus, mammalian REV3L shoulders more important functions besides handling point mutations. Constitutive and induced expression of this gene is associated with levels of genome stability.
Pan et al. 18 reported human Pol Zeta is significantly downregulated in human lung, stomach and colorectal cancers. Given the essentiality of REV3L in genomic stability, we therefore hypothesize that variants in REV3L, the human catalytic subunit of Pol zeta, are associated with the lung cancer susceptibility. To investigate the association of REV3L with lung cancer risk as well as gene --environment interactions, we genotyped 15 polymorphisms in 517 cancer-free controls and 500 lung cancer cases in a Chinese population. Three single nucleotide polymorphisms (SNPs) were significantly associated with lung cancer risk. One of the polymorphisms located in the 3 0 -terminal untranslated region (3 0 UTR) has been proved to be functional, participating in the miRNA-mediated interplay. We further demonstrated that REV3L was downregulated in human lung cancer tissues, acting as a tumor suppressor gene.
RESULTS

REV3L polymorphisms are associated with lung cancer risk
We investigated and validated the association between REV3L variants and risk of lung cancer in two independent case --control studies in a Chinese Han population. The characteristics of lung cancer patients and controls in study 1 and study 2 were previously described. 19, 20 All markers were in Hardy --Weinberg equilibrium in the control subjects (P40.05). The minor allele frequency for each polymorphism in our control subjects was also similar to that published for the Chinese population included in the HapMap database or dbSNP database (Table 1) . We genotyped 15 SNPs of REV3L gene in study 1. Three SNPs showed significant differences in minor allele frequencies between the cases and the controls (P ¼ 0.015 of rs465646, P ¼ 0.049 of rs459809 and P ¼ 0.009 of rs1002481) ( Table 1) .
Because of the relatively small number of variant homozygotes (o5%) observed in both cases and controls, there was not enough statistical power to detect any effect among variant homozygotes. To enhance statistical power, autosomal SNPs were modeled in a dominant mode of inheritance (heterozytotes þ mutant homozygotes vs wild homozygotes), if the frequency of variant homozygotes was o10%, and codominant mode of inheritance (heterozytotes vs wild homozygotes, variant homozygotes vs wild homozygotes), if the variant homozygotes frequency was at least 10%. Further logistic regression analyses revealed that after adjustment for confounding factors, significantly decreased lung cancer risk was observed for the rs465646 TC and CC genotypes (adjusted OR ¼ 0.69, 95% confidence interval (CI) 0.53 --0.90; P ¼ 0.007) and the rs1002481TA and AA genotypes (adjusted OR ¼ 0.68, 95% CI 0.52 --0.90; P ¼ 0.006), compared with their wildtype genotypes. Moreover, the CC genotype of rs459809 showed a significantly increased risk of lung cancer with OR of 1.44 compared with the TT genotype (Supplementary Table S1 ).
Of the three SNPs significantly associated with lung cancer risk, rs465646 was of the most interest because this polymorphism showed the potential to be functional for the following reasons: (1) this SNP is located in the 3 0 UTR, which is considered a regulatory region. (2) This 3 0 UTR 460T4C SNP resides in a rather conserved region among species (Supplementary Figure S1) . Replacement of the allele T to C may completely or partially impair the function of this region. (3) Bioinformatics tools, Targetscan (http://www.targetscan.org) and Pictar (http://www.pictar.mdc-berlin.de), both predicted that the REV3L 3 0 UTR harbors two binding sites for miR-25/32/92/ 363/367 for the following reasons ( Figure 1a) . Interestingly, this SNP is located within one of these binding sites. Therefore, this polymorphism was most likely to be functional in modulating mRNA::miRNA interaction (Supplementary Figure S2) .
The functional significance of the 3 0 UTR 460 T4C polymorphism prompted us to validate the observed association between this polymorphism and risk of lung cancer in another case --control study. The replication study (study 2) used another 572 lung cancer cases and 547 controls. As shown in Table 2 , we found a similar protective effect of TC and CC genotype against lung cancer risk (adjusted OR ¼ 0.72, 95% CI 0.55 --0.94; P ¼ 0.016), further confirming our results from study 1. There was no statistical heterogeneity between the two studies (P ¼ 0.767), and combined results by pooling studies 1 and 2 generated a To investigate whether the predicted two miRNA-binding sites participate in REV3L expression regulation, luciferase assays were performed. Downstream of the luciferase gene was inserted by the REV3L complete 3 0 UTR (pGL-T), 3 0 UTR with a 11-bp deletion in the upstream predicted miRNA-binding site (pGL-DmiR) or 3 0 UTR with both deletions for the predicted two miRNA-binding sites (pGL-DDmiR) (Figure 1b ). After transfection with pGL-T, pGL-DmiR or pGL-DDmiR for 24 h, the relative luciferase activities were assayed using Renilla luciferase activity for normalization. We found that loss of the upstream miRNA-binding site (pGL-DmiR) enhanced the reporter gene activity by 1.9 --2.2-fold, compared with control (pGL-T) in human embryonic lung fibroblast cell line (HELF) (with the TT genotype), H1299 (with the CC genotype) and H460 cells (with the TT genotype, Supplementary Figure S3 ); in addition, loss of both miRNA-binding sites (pGL-DDmiR) significantly elevated levels of the reporter gene expression by 2.5 --4.3-fold, compared with control vector in three cell lines (Figure 1c) .
Among predicted miRNAs, both miR-25 and miR-32 were the most common miRNAs in miRNA expression profiles of the lung or lung cancer. 21 To further explore whether these two miRNAs participated in REV3L expression regulation, we contransfected with miR-25 or miR-32 and the luciferase reporter plasmid pGL-T, pGL-DmiR or pGL-DDmiR in HELF cells. Luciferase activity was significantly reduced by miR-25 or miR-32 in pGL-T-transfected cells, compared with the control (cotransfected with an unrelated 
T-allele 3
0 UTR RNA shows a stronger binding affinity to miRNAs
As bioinformatics tools predict that the T to C change may alter the binding motif between REV3L mRNA and miRNAs (Supplementary Figure S2 ), to determine the affinity between miR-25/32 and the wild-type or variant RNA in cytoplasmic extracts, we used surface plasmon resonance (SPR) to monitor the mRNA::miRNA interaction signals. Single-stranded RNA oligonucleotides carrying the wild-type (the T allele) or variant (the C allele) sequence were each immobilized to a separate channel. Synthesized miR-25 or miR-32 at different concentrations was subjected in a single run. Kinetic binding constants were determined directly from the SPR traces using the Biorad ProteOn manager software (Bio-Rad Laboratories, Hercules, CA, USA). Sensorgrams for the two channels that contained immobilized T-allele 3 0 UTR RNA and C-allele 3 0 UTR RNA revealed that they interacted significantly with miR-25 and miR-32, respectively ( Figure 2 ). We observed a stronger binding of mRNA carrying the T-allele, than that of the C-allele, to both miR-25 (2.66 Â 10 À9 M vs 3.18 Â 10 À9 M) and miR-32 (3.80 Â 10 À9 M vs 4.45 Â 10 À9 M). These results indicated higher binding affinities for the wild-type T-allele RNA to bind to miR-25 and miR-32.
The 3
0 UTR 460 T4C polymorphism enhances reporter gene expression As mentioned above, the rs465646 SNP is located within the predicted upstream miRNA-binding site. The T to C change may modulate the REV3L mRNA::miRNA imperfect complementarities (Supplementary Figure S2) , and thus may alter gene expression. The binding affinity between REV3L mRNA and miRNAs was attenuated because of the T4C allelic change. To illustrate whether or not this variation could have an effect on gene expression, we evaluated expression differences between the two alleles. Significant differences in expression levels were observed between the major T-and minor C-allele-containing vectors (Figure 1e ). The plasmid containing the minor C allele displayed 35% significantly higher levels of luciferase expression than that of the plasmid with the T allele in the HELF and H1299 cells. Forced expression of miR-25 or miR-32 downregulated both pGL-T and pGL-C vectors, whereas the C-allele-containing plasmids still showed a significantly higher reporter activity (Figure 1e ). These results indicated that individuals with the protective C allele are likely to express an adequate amount of REV3Lp, which may protect cells against genome instability. miRNAs can downregulate endogenous REV3L expression via translation inhibition Even though we have demonstrated that miR-25/32 could downregulate the reporters carrying REV3L 3 0 UTR, the influence of miR-25/32 on endogenous REV3L was still unclear. As the fulllength REV3L cannot be detected by western blotting, we determined the REV3L protein by direct immunofluorescence, as described by Brondello et al. 17 Chemically synthesized RNAs (miR-25, miR-32 and 32bp REV3L 3 0 UTR RNAs) were transfected into H1299 (with CC genotype) and HELF (with TT genotype) cells, respectively. Results of immunofluorescent staining showed that the REV3L protein was mainly localized in the nucleus. Fluorescent signals were reduced in miR-25 or miR-32-transfected cells (Figure 3a and Supplementary Figure S4 ). However, the mRNA level of REV3L or luciferase was not decreased after transfection of miR-25/32 (Figures 3bi and 3bii) . In addition, the strongest fluorescent signal was observed in cells transfected with a synthesized short REV3L 3 0 UTR RNA, which could competitively bind to the endogenous miR-25/32 ( Figure 3a and Supplementary Figure S4 ). These results demonstrated that miR-25/32 could downregulate endogenous REV3L expression by translation inhibition. Interaction 0 UTR mutant-C-allele RNA was immobilized to a streptavidin-modified sensor chip. Cytoplasmic extracts from the H1299 cells were incubated with miR-25 or miR-32 at different concentrations to compare the relative binding affinities. The SPR measurements were conducted using a 6 Â 6 channels ProteOn XPR36 protein interaction array system (Biorad). (a) Binding affinity of REV3L 3 0 UTR T or C containing RNA to miR-25 was monitored. The SPR-binding signal of the T-allele seuquence interaction with miR25 was higher than that of C-allele with miR-25. (b) Binding affinity of REV3L 3 0 UTR T-or C-allele containing RNA to miR-32 was monitored. The SPR-binding signal of the T-allele seuquence interaction with miR32 was higher than that of C-allele with miR-32.
microRNA polymorphism in lung cancer susceptibility S Zhang et al REV3L overexpression diminishes foci formation To further determine the role of REV3L in cell transformation, we performed foci formation assays. As shown in Figure 4a and Supplementary Figure S5 , HELF and H1299 cells transfected with a REV3L expression vector formed less foci than cells transfected with the control pcDNA3.1 vector. Furthermore, cell foci were significantly increased in cells transfected with a REV3L-RNAi vector compared with cells transfected with control plasmid. Similar results were also obtained by stable cell lines. These data suggested that overexpression of REV3L could attenuate cellular proliferation and transformation.
We then evaluated the influence of the T4C SNP on the foci formation. Synthesized partial REV3L 3 0 UTR RNA (32 bp) carrying either T-or C-allele was transfected into HELF and H1299 cells, in which they may bind competitively to the endogenous miRNAs in individual manner. As short half-time (5 days in the cytoplasm) of synthesized 2 0 -methoxy-modified RNA oligonucleotides (32 bp), we also performed a second transfection 5 --7 days after the first transfection. For once-transfected or twice-transfected experiments, the results are similar. As demonstrated by SPR that the exogenous T-allele RNA competed more efficiently for the binding to the endogenous miRNAs, cells transfected with partial 3 0 UTR T-allele-RNA generated fewer colonies compared with those with the C-allele-RNA (o0.5 fold, Figure 4b) , indicating a higher endogenous REV3L expression in T-allele-RNA transfected-cells. Therefore, it is likely that the endogenous REV3L T-allele-mRNA was more negatively regulated by miRNAs than the C-allele counterpart, resulting in less REV3L expression.
REV3L mRNA is downregulated in lung cancer tissues
To assess the expression of REV3L in normal lung and lung cancer tissues, we quantified the levels of REV3L transcripts in tumor samples from 46 lung cancer patients. We found that cancerous tissues exhibited significantly fewer REV3L transcripts compared with corresponding adjacent normal counterparts (P ¼ 0.017, Figure 5 ), which led us to conclude that REV3L expression was decreased in lung cancer. This result was consistent with the report from Pan et al., 18 though inconsistent with our findings in gliomas. 22 Therefore, dysregulation of REV3L expression may be tissue-specific.
DISCUSSION
We identified a mechanism to explain the association of 3 0 UTR 460 SNP of REV3L with lung cancer susceptibility through posttranscriptional gene regulation by miRNAs::mRNA interaction. Our first association study explored 15 common SNPs and identified three polymorphisms associated with lung cancer risk. The 0 UTR 460 SNP and lung cancer risk was validated in another independent case --control study. These results strongly support that genetic variation of the REV3L gene may modulate the lung cancer risk. Addiditional luciferase assays experiments further showed that the 3 0 UTR 460 SNP was located within a miRNAs-binding site. It appeared that the T4C change caused relaxed mRNA::miRNA binding and consequently led to an elevated levels of REV3L expression.
Among the TLS polymerases, only Pol Z was found to be responsible for bypassing UV lesions in DNA, and its absence may result in the variant form of the genetic disorder, xeroderma pigmentosum variants. 7, 23 Other TLS polymerases have specificities for different types of DNA damage, but their precise roles inside the cell have not yet been established. The REV3L gene, encoding the catalytic subunit of human polymerase z, has a significant role in mutagenicity. Comparatively, Pol z is much more efficient at extending from base mispairs than it is at creating the mispairs. 5 However, there has been no association study or pedigree study on this gene and its association with risk of cancers.
Genome instability is a hallmark of all tumors, including lung cancer, and genomic instability is characterized by an increased frequency of chromosomal aberrations and gene mutations in cells, which result from an elevated rate of DNA damage or an attenuated capability of DNA repair. 24 Mammalian cells with the homologous REV3L deletion did not proliferate in vitro, perhaps because of unrepaired aberrations activating the checkpoint control.
12 hREV3L gene encodes a 353-kDa protein, which is twice the size of yeast REV3 (173 kDa). 25, 26 Much of this difference is because of the exon 13, which encodes 1388 amino-acid residues. 9 This uncharacterized region is believed to render this large molecule with new functions. Our results in colony formation indicated that REV3L could attenuate the proliferation of cells, which reduced the possibility of cancer development. In addition, results of the real-time PCR also disclosed a significant reduction of REV3L expression in 46 lung carcinomas, compared with that of the normal adjacent tissues. The protective role of REV3L conflicts with the traditional concept that the low-fidelity enzyme accelerates cancer development by causing mutations. 10, 27 Recent findings also support the tumor suppressor role of REV3L, 17 consistent with our results.
Regulation of the REV3L expression has been focused on its transcription. REV3L (mice REV3) is inducible by N-methyl-N'-nitroNnitrosoguanidine, adriamycin and pentylenetetrazole. 16, 28, 29 Little is known about the posttranscriptional regulation of REV3L. MicroRNAs are B22 nucleotide small non-coding RNAs that regulate gene expression by targeting their 3 0 UTRs. 30 miRNAs that only partially complement their corresponding mRNAs are important in regulating gene expression. The fate of the targeted mRNA is determined by the extent of complementary pairing between the miRNA and its targeted mRNA. 31 A high degree of complementary binding increases the chance for cleavage that leads to digestion of target mRNAs. 32 Our data in SPR showed a higher affinity for the T allele of 3 0 UTR 460 SNP to bind to miRNAs, resulting in reduced expression, which is in line with this concept. Therefore, the 3 0 UTR 460T4C change modulates the binding pattern and consequently leads to the altered expression. We confirmed our prediction that miR-25 and miR-32 interacted with REV3L mRNA. 3 0 UTR polymorphisms at miRNA target sites can modulate gene expression through alteration of miRNA target-binding capability, ultimately leading to differences in the susceptibility to complex genetic diseases, such as cancer.
However, because the prevalence and importance of miRNAs have been recognized in recent years, only a few studies have described the polymorphisms associated with binding miRNAs. 33 --35 Clop et al. 36 reported a mutation in the 3 0 UTR of the myostatin gene that is responsible for the characteristic muscular hypertrophy of Texel sheep owing to the creation of a de novo miRNA-binding site A variation in the 3 0 UTR of fibroblast growth factor 20 is associated with Parkinson's disease and disrupts a binding site for microRNA-433. 37 A 3 0 UTR SNP in human dihydrofolate reductase (DHFR) affects its expression by interfering with miR-24 function, resulting in DHFR overexpression and methotrexate resistance. However, this SNP is located out of the miR-24-binding site. 38 In our study, the 3 0 UTR 460 T4C SNP at least modulates the interaction between mRNA and miR-25/32 rather than only one miRNA. As for the other predicted miRNAs, including miR-92, miR-363 and miR-367, their roles need to be further investigated. The final REV3L expression appears to be comprehensively regulated by these miRNAs, but the competitive relationship among these miRNAs remains elusive.
Having extended our previous association study, we successfully identified the risk-contributing polymorphism in the REV3L gene and portrayed a possible underlying mechanism in carcinogenesis. Larger studies involving ethnically diverse populations are warranted to confirm our findings.
MATERIALS AND METHODS
Study population and sampling
The first association study (study 1) included 500 lung cancer patients and 517 cancer-free controls. As previously described, 19 all subjects were genetically unrelated ethnic Han Chinese. The case patients were recruited between July 2002 and December 2004 in Nanjing, Jiangsu province, China. Cancer-free controls were enrolled from a pool of 10 500 individuals from communities in Jiangsu province. Study 2 included an additional 572 lung cancer patients and 547 controls. Eligible cases with incident lung cancer were consecutively recruited between October 2003 and July 2006 from four hospitals in Shanghai whereas the controls were from Yangpu and Jingan District, Shanghai, China. The detailed population information and population features of study 2 are summarized in our previously published paper. 20 In both studies, the controls were frequency-matched to the cases by age (±5 years), sex and residential area (urban or countryside). After a written informed consent, each participant was scheduled for an interview, where a structured questionnaire was administered by interviewers to collect information on demographic data and environmental exposure history, including tobacco smoke. Lung cancer tissues and corresponding adjacent normal lung tissues were obtained from 46 patients receiving surgery at Changhai Hospital, Shanghai, China. All patients who provided samples gave a written informed consent for their tissues to be used for scientific research. These tissues were immediately frozen and stored at À80 1C for the real-time PCR analysis.
All of the above studies were approved by the institutional review board of Fudan University and Nanjing Medical University.
Selection of REV3L SNPs
The human REV3L gene encompasses 184.7 kb, located on chromosome 6q21. As this study was initiated in January 2005, when the SNP density of the phase I HapMap SNP database was not adequate, we chose SNPs from both the HapMap and dbSNP databases. The genetic model of REV3L reveals 33 exons and 32 introns with 902 SNPs, as listed in the dbSNP Build 121. To capture the majority of common variants across this gene, an algorithm to score the SNPs was developed, and a set of SNPs were selected on the basis of their final scores. The detailed procedure has been described elsewhere. 39 In brief, for a SNP, the following criteria were considered: (i) interdistance between two adjacent SNPs; (ii) heterozygosity; (iii) functional relevance and (iv) compatibility with the genotyping platform. As a result, 15 SNPs (rs181294, rs465646, rs457497, rs240998, rs240969, rs240966, rs459809, rs464401, rs240993, rs462779, rs1002481, rs6922226, rs6937734, rs6935759 and rs6913769) were selected for genotyping in this study.
Genotyping
The genomic DNA was extracted from venous blood samples taken from every participant, using the kits of guanidine hydrochloride bought from microRNA polymorphism in lung cancer susceptibility S Zhang et al the company of QIANGEN (Hilden, Germany). The 15 SNPs were genotyped by using the Illumina Genotyping Facility, which is a highly efficient genotyping assay that combines Illumina Golden Gate assay, Sentrix array matrices and Sherlock scanner technology (Illumina Corp, Foster City, CA, USA) at the Chinese National Human Genome Center in Shanghai, China. More detailed description of each of the steps performed by the Illumina Genotyping Facility is available in our previously published paper. 19 In study 2, the samples were genotyped using SNPScan technology (Generay, Shanghai, China). Of all assays, 5% of samples were randomly selected and tested by sequencing, and the reproducibility was 100%.
Construction of promoter reporter plasmids
For the effect of the 3 0 UTR 460 T/C SNP on posttranscriptional regulation of REV3L, a fragment containing the REV3L 3 0 UTR ( þ 1 to þ 837, relative to translational stop codon) carrying the major T allele at the position þ 460 bp (pGL-T) was amplified by PCR, using the following primers:
(forward) and 5 0 -GCTCTAGACCCAAGCTTCGCGTGAGCCCACCTGGAG-3 0 (reverse). The mutant (pGL-C) was made using the following primers: 5 0 -CTTTTCAAACGAG CAAAATAATGTGC-3 0 (forward) and 5 0 -GCACATTATTTTGCTCGTTTGAAAAG -3 0 (reverse). In addition, the pGL-DmiR construct, which lost an 11-bp putative miRNA seed sequence was generated using the following primers: 5 0 -TTCAAACGAGTAAAAGATTTTTATACAAATG-3 0 (forward) and 5 0 -CAT TTGTATAAAAATCTTTTACTCGTTTGAA-3 0 (reverse). The pGL-DDmiR construct, which lost another 10 bp putative miRNA seed sequence was generated using the following primers: 5 0 -TGTTACAAACCTGTGGG CACTTTAAAAAT-3 0 (forward) and 5 0 -GAATAAAATTTTTTATTTTTAAA GTGCCCACAGGT-3 0 (reverse). Each amplified fragment was digested by XbaI and inserted downstream of the firefly luciferase gene in a pGL3-promoter vector (Promega, Madison, WI, USA). These recombination plasmids were sequenced to confirm their orientation.
Cell culture and transfection HELF human embryonic lung fibroblasts were cultured in Dulbecco's modified Eagle medium supplemented with 10% fetal bovine serum (Gibco, Grand Island, NY, USA). H460 human lung adenocarcinoma cells and H1299 human non-small cell lung cancer cells were cultured in RPMI 1640 with 10% fetal bovine serum. For H1299 cells, medium was additionally supplemented with 10 mM HEPES ((4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid) and 1 mM sodium pyruvate. Cells were grown in a 37 1C incubator with 5% CO 2 .
For transfection, cells were grown on 24-well culture plates with 70 --80% confluence. Cells were transfected by Lipofectamine 2000 transfection reagent (Invitrogen, Carlsbad, CA, USA) with 1 mg of the pGL-T, pGL-C, pGL-DmiR or pGL-DDmiR vector containing REV3L 3 0 UTR fragment coupled to the firefly luciferase reporter gene, respectively. Chemically synthesized RNAs, including miR-25, miR-32, miR-25/32 inhibitors, 3 0 UTR-T-allele RNA and 3 0 UTR-C-allele RNA were obtained from GenePharma (GenePharma, Shanghai, China). For co-transfection, cells were transfected with 0.5 mg of the pGL-T, pGL-C, pGL-DmiR or pGL-DDmiR vector and 0.5 mg of the chemically synthesized RNA. In each transfection, 50 ng of pRL-TK (Promega) was used to correct for transfection efficiency. After incubation for 24 h, cells were broken using passive lysis buffer.
Luciferase assays
Luciferase activity was measured with the Dual-Luciferase Reporter Assay System (Promega). Promoter activities were expressed as the ratio between Firefly luciferase and Renilla luciferase activities.
Quantitative analysis of REV3L mRNA and miRNAs RNA was extracted and converted to complementary DNA using an oligo(dT) 12 primer and Superscript II (Invitrogen). The SYBR green dye (Takara Bio Inc., Shiga, Japan) was used for the amplification of complementary DNA. REV3L and internal standard glyceraldehyde 3-phosphate dehydrogenase (GAPDH) RNA were measured by the real-time quantitative reverse transcriptase PCR in triplicates on a Prism 7900 RealTime PCR machine (Applied Biosystems, Foster City, CA, USA) with primers as follows: for glyceraldehyde 3-phosphate dehydrogenase, 5 0 -GAAGGTGAAG GTCGGAGTC-3 0 (sense), 5 0 -GAAGATGGTGATGGGATTTC-3 0 (antisense); for REV3L, 5 0 -CGCGTCAGTTGGGACTTAAG-3 0 (sense), 5 0 -ACTATCGCCAACCTCA ATGC-3 0 (antisense).
SPR experiments
The SPR measurements were conducted using a 6 Â 6 channels ProteOn XPR36 protein interaction array system (Biorad, Hercules, CA, USA). Biotinlabeled single-stranded RNA harboring 32 bp 3 0 UTR wild-type-T-allele RNA (5 0 -CUUUUCAAACGAGTAAAAUAAUGUGCAAUGAU-3 0 ) or 3 0 UTR mutant-Callele RNA (5 0 -CUUUUCAAACGAGCAAAAUAAUGUGCAAUGAU-3 0 ) (400 mM) was immobilized to a streptavidin-modified sensor chip. Cytoplasmic extracts from the H1299 cells were incubated with miR-25 or miR-32 at different concentrations to compare the relative binding affinities. The flow rate was 50 ml/min, and the binding between RNAs was monitored for 400 s. The SPR experiment was conducted at room temperature, and the data was evaluated using the Biorad ProteOn manager software. For regeneration of the immobilized RNA, 0.1% SDS was applied for 2 --3 min after each cycle of protein binding.
Immunostaining
H1299 and HELF cells were fixed with 4% paraformaldehyde, washed with phosphate-buffered saline and permeabilized with 1% Triton X-100 in phosphate-buffered saline. Cells were blocked with blocking buffer (phosphate-buffered saline, 1% Triton X-100 and 5% bovine serum albumin) and incubated at 4 1C with the REV3L antibody (1:1000; Abnova, Taiwan, China) overnight. FITC-conjugated goat anti-mouse (1:100) was incubated for 30 min at room temperature. Nuclear counterstaining was performed using 4,6-diamidino-2-phenylindole (DAPI) (Sigma-Aldrich, St Louis, MO, USA). Cells without the treatment of the primary antibody served as negative control.
Statistical analysis
The Hardy --Weinberg equilibrium test was performed for each genotyped SNP among controls. Differences in demographic characteristics, selected variables and frequencies of the genotypes of REV3L variants between the cases and the controls were evaluated using the Pearson's w 2 testing. The associations between REV3L variants and lung cancer risk were estimated by computing the ORs and their 95% CIs from both univariate and multivariate logistic regression analyses with adjustment for age, sex, smoke status and family history of cancer.
Other data were expressed as the mean ± s.e. from at least three independent experiments, unless indicated otherwise. s.e. bars were included for all data points. The relative mRNA level between lung cancer tissues and normal tumor-adjacent tissues was calculated by Student's two-tailed, paired t-test. Other statistical differences between test and control values were analyzed by means of Student's two-tailed, unpaired t-test. All the statistical analyses were performed with the SPSS 15.0 software (SPSS, Chicago, IL, USA). Data were considered significant and were indicated by '*' if Po0.05 vs control and '**' if Po0.01.
